In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From Nordic Group BV

AstraZeneca/Daiichi Sankyo’s Enhertu To Get Lung Cancer Label For EU

The European Medicines Agency has recommended new uses for 11 approved medicines, including an antibody drug conjugate for treating advanced non-small cell lung cancer.

Europe Approvals

Keytruda & Bavencio Win EU Nod For More Cancers

The European Medicines Agency has recommended that the therapeutic indications of Keytruda and Bavencio should be expanded again.

Europe Cancer

Deals Shaping The Medical Industry, February 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in January 2017

Deals BioPharmaceutical

Taiho Oncology Prepares To Commercialize Products In U.S., Europe

The business unit is transitioning from being the clinical development arm of its parent company to a full-blown commercial operation in the U.S. and Europe.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
  • Distributors
  • Pharmaceuticals
  • Services
  • Services
    • Hospitals, Nursing Homes, Institutions
  • Biotechnology
    • Large Molecule
  • Other Names / Subsidiaries
    • Nordic Drugs
    • Nordic Pharma
    • Disphar International
    • Indeus Life Sciences
    • Prague Clinical Services
    • QPharma